Page 104 - 73_02
P. 104

HERBERT ZIMMERMANN Y COLS.  AN. R. ACAD. NAC. FARM.

(74)  DENNIS, J.; NOGAROLI, L. and FUSS, B. (2005): Phosphodiesterase-I alpha-/
(75)  autotaxin (PD-I alpha/ATX): A multifunctional protein involved in central
(76)  nervous system development and disease. J. Neurosci. Res. 82: 737-742.
(77)  DE BACKER, M.; MCSWEENEY, S.; RASMUSSEN, H. B.; RIISE, B. W.; LINDLEY, P. and
(78)  HOUGH, E. (2002): The 1.9 Å crystal structure of heat-labile shrimp alkaline
(79)  phosphatase. J. Mol. Biol. 318: 1265-1274.
(80)  YEGUTKIN, G. G.; MIKHAILOV, A.; SAMBURSKI, S. S. and JALKANEN, S. (2006): The
      detection of micromolar pericellular ATP pool on lymphocyte surface by
(81)  using lymphoid ecto-adenylate kinase as intrinsic ATP sensor. Mol. Biol. Cell.
(82)  17: 3378-3385.
(83)  SCHULTZ-HEIENBROK, R.; MAIER, T. and STRÄTER, N. (2005): A large hinge
(84)  bending domain rotation is necessary for the catalytic function of Escherichia
(85)  coli 5'-nucleotidase. Biochemistry USA. 44: 2244-2252.
      STRÄTER, N. (2006): Ecto-5‘-Nucleotidase: Structure function relationships.
(86)  Purinergic Signalling. 2: 343-350.
      CUNHA, R. A. (2001): Regulation of the ecto-nucleotidase pathway in rat
      hippocampal nerve terminals. Neurochem. Res. 26: 979-991.
      KOSZALKA, P.; OZUYAMAN, B.; HUO, Y. Q.; ZERNECKE, A.; FLOGEL, U.; BRAUN, N.;
      BUCHHEISER, A.; DECKING, U. K. M.; SMITH, M. L.; SÉVIGNY, J.; GEAR, A.; WEBER,
      A. A.; MOLOJAVYI, A.; DING, Z. P.; WEBER, C.; LEY, K.; ZIMMERMANN, H.; GODECKE,
      A. and SCHRADER, J. (2004): Targeted disruption of cd73/ecto-5'-nucleotidase
      alters thromboregulation and augments vascular inflammatory response.
      Circ. Res. 95: 814-821.
      SCHUBER, F. and LUND, F. E. (2004): Structure and enzymology of ADP-ribosyl
      cyclases: conserved enzymes that produce multiple calcium mobilizing
      metabolites. Curr. Mol. Med. 4: 249-261.
      SEMAN, M.; ADRIOUCH, S.; HAAG, F. and KOCH-NOLTE, F. (2004): Ecto-ADP-
      ribosyltransferases (ARTs): Emerging actors in cell communication and
      signaling. Curr. Medicinal. Chem. 11: 857-872.
      ALVARADO-CASTILLO, C.; HARDEN, T. K. and BOYER, J. L. (2005): Regulation of
      P2Y1 receptor-mediated signaling by the ectonucleoside triphosphate
      diphosphohydrolase isozymes NTPDase1 and NTPDase2. Mol. Pharmacol. 67:
      114-122.
      MARCUS, A. J.; BROEKMAN, M. J.; DROSOPOULOS, J. H. F.; ISLAM, N.; PINSKY, D. J.;
      SESTI, C. and LEVI, R. (2003): Metabolic control of excessive extracellular
      nucleotide accumulation by CD39/ecto-nucleotidase-1: Implications for
      ischemic vascular diseases. J. Pharmacol. Exp. Ther. 305: 9-16.
      SÉVIGNY, J.; SUNDBERG, C.; BRAUN, N.; GUCKELBERGER, O.; CSIZMADIA, E.; QAWI, I.;
      IMAI, M.; ZIMMERMANN, H. and ROBSON, S. C. (2002): Differential catalytic
      properties and vascular topography of murine nucleoside triphosphate
      diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for
      thromboregulation. Blood. 99: 2801-2809.
      ATKINSON, B.; DWYER, K.; ENJYOJI, K. and ROBSON, S. C. (2006): Ecto-
      nucleotidases of the CD39/NTPDase family modulate platelet activation and
      thrombus formation: Potential as therapeutic targets. Blood Cells Molec. Dis.
      36: 217-222.

562
   99   100   101   102   103   104   105   106   107   108   109